Antiplatelet and anticoagulation therapy for acute coronary syndromes.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 24902976.
- Also identified by DOI 10.1161/CIRCRESAHA.114.302737.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The past 2 decades have witnessed the introduction and demise of several different antithrombotic medications for acute coronary syndromes. Part of the assessment of these compounds has been their effect on thrombotic events relative to the degree of increase in bleeding events. This review will outline the data supporting various antiplatelet and anticoagulant therapies and their combinations in patients with acute coronary syndromes and related disorders in both the acute and chronic phases of therapy.
Medical subject headings
- Acute Coronary Syndrome
- Anticoagulants
- Myocardial Infarction
- Platelet Aggregation Inhibitors